Literature DB >> 4640954

Growth hormone: metabolic clearance rates, integrated concentrations, and production rates in normal adults and the effect of prednisone.

R G Thompson, A Rodriguez, A Kowarski, R M Blizzard.   

Abstract

A constant withdrawal pump was used to determine the integrated concentration of growth hormone (ICGH) which was used in conjunction with the metabolic clearance rate (MCR) of growth hormone (GH) to calculate the GH production rates (GHPR) in normal adults, acromegalics, and normal controls receiving prednisone. The mean ICGH for 22 premenopausal females on no medication was 3.0+/-1.6 ng/ml (sd) which is significantly lower (P < 0.005) than the mean of 6.6+/-2.9 for 10 women receiving oral contraceptives and significantly higher than the means of 1.5+/-0.75 for 5 postmenopausal females (P < 0.05) and 1.8+/-1.0 for 16 adult males (P < 0.01) which are comparable. The mean GHPR's in mg/24 hr per m(2) for the four groups are: normal females = 0.52+/-0.24 (sd), females receiving contraceptive pills = 1.65+/-0.58 (P < 0.005), postmenopausal females = 0.26+/-0.12 (P < 0.025), and adult males 0.35+/-0.23 (P < 0.025).Three untreated acromegalic patients had ICGH's of 59, 82, and 93 ng/ml and GHPR's ranging from 14.5 to 17.9 mg/24 hr. Prednisone in a dose of 20 mg t.i.d. for 8 days significantly decreased both the ICGH and GHPR. Alternate day prednisone (60 mg in a single q.o.d. dose) resulted in less consistent inhibition of GH release which may play a role in the more normal growth seen in children receiving q.o.d. prednisone.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4640954      PMCID: PMC333001          DOI: 10.1172/JCI107146

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  25 in total

1.  Human growth hormone release during sleep: electroencephalographic correlation.

Authors:  D C Parker; J F Sassin; J W Mace; R W Gotlin; L G Rossman
Journal:  J Clin Endocrinol Metab       Date:  1969-06       Impact factor: 5.958

2.  A technic for continuous in vivo sampling of blood through an 18-gauge channel.

Authors:  J B McKendry
Journal:  Metabolism       Date:  1968-02       Impact factor: 8.694

3.  Adrenal function, growth, and insulin in patients treated with corticoids on alternate days.

Authors:  A Sadeghi-Nejad; B Senior
Journal:  Pediatrics       Date:  1969-02       Impact factor: 7.124

4.  Responses of plasma growth hormone and corticosteroids to insulin and arginine with or without prior administration of dexamethasone.

Authors:  K Nakagawa; Y Horiuchi; K Mashimo
Journal:  J Clin Endocrinol Metab       Date:  1969-01       Impact factor: 5.958

5.  Comparison of arginine infusion and diethylstilbestrol as a means of provoking growth hormone secretion.

Authors:  G E Bacon; G H Lowrey; M Knoller
Journal:  J Pediatr       Date:  1969-09       Impact factor: 4.406

6.  Sex-determined variation in serum insulin and growth hormone response to amino acid stimulation.

Authors:  T J Merimee; J A Bergess; D Rabinowitz
Journal:  J Clin Endocrinol Metab       Date:  1966-07       Impact factor: 5.958

7.  Effect of pyrogen on blood levels of pituitary trophic hormones. Observations of the usefulness of the growth hormone response in the detection of pituitary disease.

Authors:  P O Kohler; B W O'Malley; P L Rayford; M B Lipsett; W D Odell
Journal:  J Clin Endocrinol Metab       Date:  1967-02       Impact factor: 5.958

8.  Plasma growth hormone concentration in corticosteroid-treated children.

Authors:  H G Morris; J R Jorgensen; S A Jenkins
Journal:  J Clin Invest       Date:  1968-03       Impact factor: 14.808

9.  Metabolic clearance rate of radioiodinated human growth hormone in man.

Authors:  D P Cameron; H G Burger; K J Catt; A Doig
Journal:  J Clin Invest       Date:  1969-09       Impact factor: 14.808

10.  Metabolic clearance and production rates of human growth hormone.

Authors:  A L Taylor; J L Finster; D H Mintz
Journal:  J Clin Invest       Date:  1969-12       Impact factor: 14.808

View more
  14 in total

1.  Growth hormone studies in patients with rheumatoid arthritis with or without glucocorticoid therapy.

Authors:  O Butenandt; A Kelch; E Rajmann
Journal:  Z Kinderheilkd       Date:  1974

Review 2.  Treatment of acromegaly.

Authors:  J P Thomas
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-29

3.  Glucocorticosteroids and growth hormone secretion under physiological conditions and in states of steroid excess.

Authors:  K E Mühlendahl; B Weber; R Müller-Hess; S Korth-Schütz; H Helge
Journal:  Eur J Pediatr       Date:  1978-06-20       Impact factor: 3.183

4.  Both estrogen receptor α and β stimulate pituitary GH gene expression.

Authors:  Dimiter Avtanski; Horacio J Novaira; Sheng Wu; Christopher J Romero; Rhonda Kineman; Raul M Luque; Fredric Wondisford; Sally Radovick
Journal:  Mol Endocrinol       Date:  2013-01-01

5.  Gender-related differences in growth hormone-releasing pituitary adenomas. A clinicopathological study.

Authors:  Bernhard Schaller
Journal:  Pituitary       Date:  2002       Impact factor: 4.107

6.  Gender- and age-related differences in the endocrine parameters of acromegaly.

Authors:  A Colao; G Amato; A M Pedroncelli; R Baldelli; S Grottoli; V Gasco; M Petretta; C Carella; G Pagani; G Tambura; G Lombardi
Journal:  J Endocrinol Invest       Date:  2002-06       Impact factor: 4.256

Review 7.  Acromegaly update--etiology, diagnosis and management.

Authors:  S Melmed; J A Fagin
Journal:  West J Med       Date:  1987-03

8.  Enhanced basal and disorderly growth hormone secretion distinguish acromegalic from normal pulsatile growth hormone release.

Authors:  M L Hartman; S M Pincus; M L Johnson; D H Matthews; L M Faunt; M L Vance; M O Thorner; J D Veldhuis
Journal:  J Clin Invest       Date:  1994-09       Impact factor: 14.808

9.  Metabolic clearance and production rates of prolactin in man.

Authors:  D S Cooper; E C Ridgway; B Kliman; R N Kjellberg; F Maloof
Journal:  J Clin Invest       Date:  1979-12       Impact factor: 14.808

10.  Effects of growth hormone administration in pediatric renal allograft recipients.

Authors:  S Bartosh; B Kaiser; I Rezvani; M Polinsky; S Schulman; J Palmer; H J Baluarte
Journal:  Pediatr Nephrol       Date:  1992-01       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.